We also found that under nutrient conditions that approximate the in vivo metabolic environment, glutaminase inhibition has only modest effects even in ENO1-deleted glioma cells, which are quite sensitive in “normal” media. The gene discussed is ENO1; the disease is central nervous system cancer.